Human sTNF RII/TNFRSF1B Quantikine ELISA Kit
| Name | Human sTNF RII/TNFRSF1B Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DRT200 |
| Category | ELISA Kit |
| Prices | $509.00, $2,440.00, $16,540.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (200 uL), Serum (20 uL), EDTA Plasma (20 uL), Heparin Plasma (20 uL), Citrate Plasma (20 uL), Urine (20 uL) |
| Sensitivity | 2.3 pg/mL |
| Range | 7.8 - 500 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma, Urine) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human sTNF RII Immunoassay is a 3.5 or 4.5 hour solid phase ELISA designed to measure human sTNF RII in cell culture supernates, serum, plasma, or urine |
| Gene | TNFRSF1B |
| Supplier Page | Shop |
Product images
Product References
Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage - Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage
Gohda T, Maruyama S, Kamei N, Yamaguchi S, Shibata T, Murakoshi M, Horikoshi S, Tomino Y, Ohsawa I, Gotoh H, Nojiri S, Suzuki Y. Sci Rep. 2017 Mar 3;7:43520.
Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to - Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to
Kulkarni M, Bowman E, Gabriel J, Amburgy T, Mayne E, Zidar DA, Maierhofer C, Turner AN, Bazan JA, Koletar SL, Lederman MM, Sieg SF, Funderburg NT. Open Forum Infect Dis. 2016 Oct 15;3(4):ofw224.
Anti-TNF-alpha Drugs Differently Affect the TNFalpha-sTNFR System and Monocyte - Anti-TNF-alpha Drugs Differently Affect the TNFalpha-sTNFR System and Monocyte
Gibellini L, De Biasi S, Bianchini E, Bartolomeo R, Fabiano A, Manfredini M, Ferrari F, Albertini G, Trenti T, Nasi M, Pinti M, Iannone A, Salvarani C, Cossarizza A, Pellacani G. PLoS One. 2016 Dec 9;11(12):e0167757.
Prevalent peripheral arterial disease and inflammatory burden. - Prevalent peripheral arterial disease and inflammatory burden.
Cauley JA, Kassem AM, Lane NE, Thorson S. BMC Geriatr. 2016 Dec 9;16(1):213.
Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the - Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the
Cauley JA, Barbour KE, Harrison SL, Cloonan YK, Danielson ME, Ensrud KE, Fink HA, Orwoll ES, Boudreau R. J Bone Miner Res. 2016 Dec;31(12):2129-2138.
Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in - Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in
Eng GP, Bouchelouche P, Bartels EM, Bliddal H, Bendtzen K, Stoltenberg M. PLoS One. 2016 Sep 8;11(9):e0162316.
Reliability of Potential Pain Biomarkers in the Saliva of Healthy Subjects: - Reliability of Potential Pain Biomarkers in the Saliva of Healthy Subjects:
Sobas EM, Reinoso R, Cuadrado-Asensio R, Fernandez I, Maldonado MJ, Pastor JC. PLoS One. 2016 Dec 1;11(12):e0166976.
Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury. - Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.
Pedigo CE, Ducasa GM, Leclercq F, Sloan A, Mitrofanova A, Hashmi T, Molina-David J, Ge M, Lassenius MI, Forsblom C, Lehto M, Groop PH, Kretzler M, Eddy S, Martini S, Reich H, Wahl P, Ghiggeri G, Faul C, Burke GW 3rd, Kretz O, Huber TB, Mendez AJ, Merscher S, Fornoni A. J Clin Invest. 2016 Sep 1;126(9):3336-50.
Stability of cytokines, chemokines and soluble activation markers in unprocessed - Stability of cytokines, chemokines and soluble activation markers in unprocessed
Aziz N, Detels R, Quint JJ, Li Q, Gjertson D, Butch AW. Cytokine. 2016 Aug;84:17-24.
Association between serum soluble tumor necrosis factor-alpha receptors and early - Association between serum soluble tumor necrosis factor-alpha receptors and early
Ouyang S, Li W, Liu Z, Li Y, Li S, Wu J. Endocr J. 2016 Jun 30;63(6):581-7.